Free Trial

Bio-Rad Laboratories (BIO) Short Interest Ratio & Short Volume

Bio-Rad Laboratories logo
$224.08 -3.06 (-1.35%)
As of 05/23/2025 03:58 PM Eastern

Bio-Rad Laboratories Short Interest Data

Bio-Rad Laboratories (BIO) has a short interest of 1.07 million shares, representing 5.77% of the float (the number of shares available for trading by the public). This marks a -5.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 318,067 shares to cover all short positions.

Current Short Interest
1,070,000 shares
Previous Short Interest
1,130,000 shares
Change Vs. Previous Month
-5.31%
Dollar Volume Sold Short
$260.84 million
Short Interest Ratio
2.8 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
27,213,000 shares
Float Size
18,540,000 shares
Short Percent of Float
5.77%
Today's Trading Volume
219,261 shares
Average Trading Volume
318,067 shares
Today's Volume Vs. Average
69%
Short Selling Bio-Rad Laboratories?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bio-Rad Laboratories and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BIO Short Interest Over Time

BIO Days to Cover Over Time

BIO Percentage of Float Shorted Over Time

Bio-Rad Laboratories Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20251,070,000 shares $260.84 million -5.3%5.8%2.8 $243.78
4/15/20251,130,000 shares $277.11 million +59.1%5.9%3.2 $245.23
3/31/2025710,400 shares $173.54 million -29.0%3.7%2.2 $244.29
3/15/20251,000,000 shares $255.34 million +15.9%5.2%3.6 $255.34
2/28/2025862,700 shares $228.27 million +41.4%4.5%3.7 $264.60
2/15/2025610,000 shares $168.70 million +4.5%3.2%3 $276.55
1/31/2025583,500 shares $211.10 million -11.9%3.1%3.3 $361.79
1/15/2025662,300 shares $227.21 million +1.0%3.5%3.6 $343.06
12/31/2024655,500 shares $215.34 million +18.8%3.4%3.6 $328.51
12/15/2024551,600 shares $185.49 million +12.9%2.9%2.8 $336.28
11/30/2024488,600 shares $166.38 million -6.8%2.6%1.7 $340.53
11/15/2024524,400 shares $167.97 million -19.5%2.7%1.8 $320.31
10/31/2024651,700 shares $233.43 million -20.8%3.4%2.2 $358.19
10/15/2024823,100 shares $281.63 million -3.3%4.3%2.8 $342.16
9/30/2024851,300 shares $285.10 million -36.9%4.5%2.7 $334.90
9/15/20241,350,000 shares $440.40 million +28.6%7.1%4 $326.22
8/31/20241,050,000 shares $354.19 million +11.7%5.5%4 $337.32
8/15/2024940,000 shares $306.41 million -26.0%4.9%3.7 $325.97
7/31/20241,270,000 shares $429.84 million -10.6%6.6%4.9 $338.46
7/15/20241,420,000 shares $429.00 million +10.9%7.2%5.6 $302.11
6/30/20241,280,000 shares $349.58 million +47.6%6.5%5.1 $273.11
6/15/2024867,500 shares $244.86 million +15.3%4.4%3.6 $282.26
5/31/2024752,200 shares $215.78 million +15.1%3.8%3.7 $286.86
5/15/2024653,400 shares $196.65 million -10.9%3.3%3.2 $300.97
4/30/2024733,100 shares $197.75 million +6.5%3.7%3.4 $269.75
4/15/2024688,500 shares $206.83 million +21.9%3.5%3.3 $300.41
3/31/2024564,800 shares $195.35 million -2.5%2.9%2.8 $345.87
3/15/2024579,300 shares $193.20 million +15.1%2.9%2.9 $333.51
2/29/2024503,400 shares $164.05 million -14.3%2.5%2.2 $325.88
2/15/2024587,100 shares $193.18 million +11.5%3.0%2.5 $329.04
1/31/2024526,700 shares $169.01 million +1.0%2.6%2 $320.89
1/15/2024521,300 shares $166.07 million +15.0%2.6%1.8 $318.56
12/31/2023453,400 shares $146.40 million -9.9%2.2%1.6 $322.89
12/15/2023503,300 shares $154.07 million -22.5%2.5%1.8 $306.12
11/30/2023649,300 shares $198.13 million +13.5%3.2%2.6 $305.14
11/15/2023572,100 shares $175.57 million +36.9%2.8%2.4 $306.89
10/31/2023418,000 shares $115.06 million +23.9%2.0%2.1 $275.27
10/15/2023337,300 shares $116.28 million +1.8%1.7%1.8 $344.73
9/30/2023331,500 shares $118.83 million -14.7%1.6%1.9 $358.45
9/15/2023388,500 shares $146.17 million -10.7%1.9%2.1 $376.23
Memorial Day Sale! 82% Off Disruptors and Dominators! (Ad)

Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.

Full of executive-quality research on the exciting world of tech investing … For just $19.
8/31/2023435,100 shares $174.13 million +6.3%2.1%2.2 $400.20
8/15/2023409,500 shares $161.70 million +21.8%2.0%1.9 $394.88
7/31/2023336,300 shares $136.30 million +1.1%1.6%1.3 $405.28
7/15/2023332,800 shares $131.98 million +17.6%1.6%1.5 $396.57
6/30/2023283,100 shares $107.27 million +0.6%1.4%1.4 $378.90
6/15/2023281,400 shares $106.67 million -26.7%1.3%1.4 $379.06
5/31/2023383,800 shares $143.29 million +31.8%1.8%2 $373.35
5/15/2023291,200 shares $111.17 million +23.2%1.4%1.5 $381.75
4/30/2023236,400 shares $106.57 million -13.9%1.1%1.3 $450.79
4/15/2023274,400 shares $131.51 million +3.5%1.3%1.7 $479.25
3/31/2023265,200 shares $127.04 million -26.8%1.3%1.6 $479.02
3/15/2023362,400 shares $173.23 million +29.9%1.7%2.2 $478.00
2/28/2023279,000 shares $133.32 million +13.8%1.3%1.7 $477.84
2/15/2023245,100 shares $112.87 million -1.9%1.2%1.5 $460.52
1/31/2023249,900 shares $116.82 million -10.1%1.2%1.4 $467.46
1/15/2023278,100 shares $126.59 million +10.1%1.3%1.3 $455.20
12/30/2022252,500 shares $106.17 million +8.8%1.2%1.1 $420.49
12/15/2022232,100 shares $97.59 million +17.2%1.1%0.9 $420.48
11/30/2022198,100 shares $82.15 million -30.3%0.9%0.8 $414.71
11/15/2022284,100 shares $119.64 million +12.7%1.3%1.2 $421.11
10/31/2022252,000 shares $88.63 million +1.3%1.2%1.2 $351.71
10/15/2022248,800 shares $98.20 million -17.7%1.2%1.4 $394.71
9/30/2022302,400 shares $126.14 million -20.1%1.4%1.9 $417.14
9/15/2022378,400 shares $178.89 million +2.9%1.8%2.6 $472.75
8/31/2022367,600 shares $178.30 million +24.0%1.7%2.5 $485.04
8/15/2022296,500 shares $162.04 million -11.6%1.4%1.8 $546.52
7/31/2022335,400 shares $188.92 million -0.8%1.6%1.8 $563.26
7/15/2022338,100 shares $167.03 million -13.0%1.6%1.7 $494.04
6/30/2022388,600 shares $192.36 million -6.3%1.8%1.8 $495.00
6/15/2022414,700 shares $199.24 million -26.4%2.0%1.9 $480.44
5/31/2022563,300 shares $302.94 million +38.1%2.6%2.6 $537.79
5/15/2022408,000 shares $204.86 million +22.6%1.9%1.8 $502.11
4/30/2022332,800 shares $170.41 million +0.8%1.6%1.4 $512.06
4/15/2022330,200 shares $181.01 million +3.5%1.6%1.4 $548.19
3/31/2022319,100 shares $179.73 million +7.2%1.5%1.4 $563.23
3/15/2022297,700 shares $163.36 million -5.1%1.4%1.4 $548.74
2/28/2022313,600 shares $196.30 million +3.0%1.5%1.5 $625.96
2/15/2022304,500 shares $188.09 million +10.1%1.4%1.6 $617.69
1/31/2022276,600 shares $165.89 million -8.0%1.3%1.8 $599.73
1/15/2022300,700 shares $188.91 million -0.2%1.4%2.3 $628.23
12/31/2021301,400 shares $227.73 million -7.3%1.4%2.7 $755.57
12/15/2021325,100 shares $241.99 million -13.7%1.5%2.9 $744.35
11/30/2021376,600 shares $283.66 million -5.5%1.8%3.3 $753.20
11/15/2021398,400 shares $300.33 million -1.7%1.9%3.4 $753.84
10/29/2021405,100 shares $321.92 million -6.1%1.9%3.4 $794.68
10/15/2021431,600 shares $311.39 million -8.0%2.0%3.6 $721.48
9/30/2021469,200 shares $350.00 million -6.1%2.2%3.9 $745.95
9/15/2021499,600 shares $394.72 million -6.3%2.4%4.1 $790.08
8/31/2021533,000 shares $428.97 million -20.3%2.5%4.7 $804.82
8/13/2021668,400 shares $520.22 million +3.6%3.2%5.6 $778.30
Memorial Day Sale! 82% Off Disruptors and Dominators! (Ad)

Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.

Full of executive-quality research on the exciting world of tech investing … For just $19.
7/30/2021645,100 shares $477.06 million +7.0%3.1%5.3 $739.51
7/15/2021602,800 shares $401.93 million +9.5%2.8%4.8 $666.77
6/30/2021550,400 shares $354.62 million -0.2%2.6%4.2 $644.29
6/15/2021551,200 shares $335.83 million -0.1%2.6%4.2 $609.27
5/28/2021551,800 shares $332.39 million +5.8%2.6%3.8 $602.37
5/14/2021521,400 shares $308.13 million -8.8%2.5%3.4 $590.97
4/30/2021571,900 shares $366.43 million -3.6%2.7%3.1 $640.73
4/15/2021593,000 shares $362.98 million +10.0%2.8%3.1 $612.11
3/31/2021539,100 shares $304.13 million -2.9%2.5%2.5 $564.15
3/15/2021555,000 shares $310.79 million -19.0%2.6%2.4 $559.98
2/26/2021685,300 shares $399.15 million +11.0%3.2%2.9 $582.45
2/12/2021617,400 shares $397.49 million +11.9%2.9%2.4 $643.81
1/29/2021551,800 shares $312.56 million -10.5%2.6%2.3 $566.44
1/15/2021616,200 shares $365.49 million -3.4%2.9%2.7 $593.14
12/31/2020637,700 shares $366.57 million +21.7%3.0%3 $574.83
12/15/2020523,800 shares $303.62 million -2.0%2.5%2.5 $579.65
11/30/2020534,400 shares $285.94 million +37.9%2.5%2.7 $535.07
11/15/2020387,600 shares $233.47 million -6.3%1.8%2.3 $602.36
10/30/2020413,700 shares $234.99 million -8.0%2.0%2.5 $568.03
10/15/2020449,600 shares $250.60 million +24.9%2.1%2.9 $557.39
9/30/2020360,000 shares $185.57 million -31.1%1.7%2.1 $515.46
9/15/2020522,600 shares $268.00 million -6.3%2.5%2.7 $512.82
8/31/2020557,700 shares $283.64 million +10.9%2.7%2.2 $508.59
8/14/2020502,800 shares $254.60 million -1.0%2.4%1.9 $506.37
7/31/2020508,100 shares $266.70 million -11.9%2.4%1.9 $524.89
7/15/2020576,400 shares $281.84 million -0.7%2.8%2 $488.96
6/30/2020580,400 shares $250.93 million +29.0%2.8%1.9 $432.34
6/15/2020449,900 shares $204.20 million +0.7%2.1%1.5 $453.88
5/29/2020446,700 shares $219.47 million -10.1%2.1%1.7 $491.32

BIO Short Interest - Frequently Asked Questions

What is Bio-Rad Laboratories' current short interest?

Short interest is the volume of Bio-Rad Laboratories shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,070,000 shares of BIO short. 5.77% of Bio-Rad Laboratories' shares are currently sold short. Learn More on Bio-Rad Laboratories' current short interest.

What is a good short interest ratio for Bio-Rad Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIO shares currently have a short interest ratio of 3.0. Learn More on Bio-Rad Laboratories's short interest ratio.

Which institutional investors are shorting Bio-Rad Laboratories?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Rad Laboratories: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Bio-Rad Laboratories?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.77% of Bio-Rad Laboratories' floating shares are currently sold short.

Is Bio-Rad Laboratories' short interest increasing or decreasing?

Bio-Rad Laboratories saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 1,070,000 shares, a decrease of 5.3% from the previous total of 1,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bio-Rad Laboratories' float size?

Bio-Rad Laboratories currently has issued a total of 27,213,000 shares. Some of Bio-Rad Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Rad Laboratories currently has a public float of 18,540,000 shares.

How does Bio-Rad Laboratories' short interest compare to its competitors?

5.77% of Bio-Rad Laboratories' shares are currently sold short. Here is how the short interest of companies compare to Bio-Rad Laboratories: Mettler-Toledo International Inc. (2.56%), Waters Co. (2.68%), Illumina, Inc. (3.51%), Bio-Techne Co. (4.13%), Charles River Laboratories International, Inc. (5.44%), Bruker Co. (7.19%), Pacific Biosciences of California, Inc. (16.40%), Harvard Bioscience, Inc. (3.36%), Thermo Fisher Scientific Inc. (1.20%), Agilent Technologies, Inc. (1.52%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Bio-Rad Laboratories stock?

Short selling BIO is an investing strategy that aims to generate trading profit from Bio-Rad Laboratories as its price is falling. BIO shares are trading down $3.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bio-Rad Laboratories?

A short squeeze for Bio-Rad Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIO, which in turn drives the price of the stock up even further.

How often is Bio-Rad Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIO, twice per month. The most recent reporting period available is April, 30 2025.




This page (NYSE:BIO) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners